All Activity

The WNBA has officially removed marijuana from its prohibited substances list while also laying out rules for how players can invest in and promote cannabis companies. At the same time, however, the women’s basketball league is also adding several psychedelics to the list of banned drugs. As part of negotiations between the Women’s National Basketball Players Association and WNBA earlier this year, the league offered to remove cannabis from its drug testing protocol. Now, under the terms of the long-form version of a new Collective Bargaining Agreement (CBA) signed by representatives of both sides, marijuana no longer appears on the prohibited substances list, whereas under the prior CBA it was included under “Drugs of Abuse.” Prior WNBA policy treated cannabis significantly more restrictively compared to the NBA, as well as multiple other professional sports leagues beyond basketball that have also adopted reforms amid the state legalization movement. First-time offenses generally resulted in treatment referrals, but repeated violations could lead to fines and suspensions. Under the new rules, players could still be subject to testing for cannabis if they enter the league’s Drugs of Abuse Program, if they are found to have been under the influence “while engaged in activities” for the team or the league or if they have “a dependency or other related issue involving the use of marijuana.” Those who are referred to a marijuana treatment program and do not comply with the rules would be subject to fines of $300 per day. Any player who exhibits a “pattern of behavior that demonstrates a mindful disregard for her treatment responsibilities” or tests positive for marijuana would face escalating penalties such as a $3,000 fine or suspension for three or more games. Players could be subject to “reasonable cause” drug testing or administrative proceedings if they are convicted of a felony involving the distribution or marijuana. At the same time WNBA and the players union are loosening up on marijuana, however, it has also added specific entries for the psychedelics dimethyltryptamine (DMT), ibogaine, psilocybin and psilocin to the prohibited substances list for the first time. Also prohibited under the new policy are synthetic cannabinoids, which the document describes as “including, but not limited to, Delta-8 tetrahydrocannabinol (also called delta-8-THC)) and their By-Products.” Separately, the CBA also addresses players’ investment in and promotion of companies that sell marijuana and hemp-derived CBD products. It says that players can hold a direct or indirect ownership interest in marijuana companies as long as the interest is passive (meaning no management, governance, voting, or executive role or other operational rights or roles” and they have less than a 50 percent stake in the business. There is also a requirement for the company to operate “in compliance with all applicable laws and regulations,” and the document specifically notes that players may not hold any ownership interest in a business “that produces or sells any products containing any Prohibited Substance or any other Schedule I or II substance under the Controlled Substances Act.” The WNBA and WNBPA have announced the following statement pic.twitter.com/ne9m4Zg7Mo — WNBA (@WNBA) May 22, 2026 While marijuana has been classified under Schedule I of the Controlled Substances Act since 1970, the Trump administration in April announced that it was moving state-licensed medical cannabis, as well as any cannabinoid products approved by the Food and Drug Administration, to Schedule III, where WNBA’s prohibition would presumably no longer apply. Broader reclassification of marijuana to Schedule III will be the topic of a hearing scheduled to begin later this month. WNBA’s rules for CBD-specific companies are looser than those for marijuana businesses in that they don’t require passive interest or less than 50 percent ownership. The document also says that players can actively promote and endorse that sell CBD products. If the products are produced by a marijuana company, however, players will first need to receive permission from the league and the union. “Without limiting such approval right of the WNBA and the Players Association, the promotion or endorsement by a player of a CBD Product that is produced or sold by a Marijuana Company (A) will not be permitted if such CBD Product is associated by the Marijuana Company with any Marijuana Product (e.g., the CBD Product is marketed or sold under a brand that also includes or refers to Marijuana Products) or if any proposed promotion creates a reasonable risk of public confusion with any Marijuana Product, and (B) if approved, shall be subject to any terms and conditions imposed by the WNBA and/or the Players Association.” “For clarity, any investments in or promotions or endorsements of entities that produce or sell products containing a form of cannabis (including, for clarity, a CBD form of cannabis) not expressly permitted…are prohibited,” the agreement that was finalized on May 22 says. “In the event a player engages in a prohibited investment, promotion, or endorsement, then, without limiting other WNBA rights or remedies, the player shall be required to promptly dispose of her ownership interest in the prohibited investment and/or immediately terminate her participation in the prohibited promotion or endorsement, as applicable.” The league gave some indication about its willingness to accept the changing tides around cannabis in 2024, when the WNBA team New York Liberty entered into a partnership with a CBD beverage company. Meanwhile, Brittney Griner—a WNBA player who was previously incarcerated in Russia over possession of marijuana—pulled out of an appearance at a cannabis event last year after discovering what she felt was a threatening message in her hotel room. Conference attendees had hoped to hear from Griner about the nature of her incarceration in Russia, which helped fuel international debate about cannabis prohibition laws domestically and abroad. How other sports leagues have navigated marijuana policy for players amid the reform movement. NBA, for its part, removed marijuana from the banned substances list for players in 2023, and it also freed them up to invest in and promote cannabis companies. The NFL, meanwhile, reached an agreement with its players union in 2024 to further reform its marijuana policies, significantly reducing fines for positive tests while increasing the allowable THC threshold for players. About four years after NFL ended the practice of suspending players over cannabis or other drugs as part of a collective bargaining agreement, the league again revised its Substances of Abuse Policy and Performance Enhancing Substances Policy. The National Collegiate Athletic Association (NCAA) in 2024 voted to remove marijuana from its banned substances list for Division I players. The reform builds on a 2022 change that increased the allowable THC threshold for college athletes, aligning NCAA’s rules with those of the World Anti-Doping Agency (WADA). In 2024, Nevada regulators officially adopted a rule change that will protect athletes from being penalized for using or possessing marijuana in compliance with state law. The head of the U.S. Anti-Doping Agency (USADA) blasted the “unfair” ban on marijuana for athletes competing in international sport events, including the Olympics that were underway in Paris at the time of the comments. USADA CEO Travis Tygart said it was “disappointing” that WADA has maintained the cannabis prohibition based on what he considers a misguided justification. WADA did carry out a review into its marijuana policy at the request of USADA and the White House Office of National Drug Control Policy (ONDCP) following the controversial suspension of U.S. runner Sha’Carri Richardson, who was barred from participating in the Olympics in 2021 after she tested positive for THC. Richardson said she used cannabis to cope with the recent passing of her mother. While UFC announced in late 2023 that it was formally removing marijuana from its modified banned substances list for athletes, the league notified participants that the reform didn’t apply under California State Athletic Commission (CSAC) rules. UFC advised fighters that they could be subject to a $100 fine by CSAS if they tested over 150 nanograms of THC per milliliter ahead of the UFC 298 event that took place in February. In 2024, NFL announced it was partnering with Canadian researchers on a clinical trial to test the safety and efficacy of CBD for pain management and neuroprotection from concussions—key issues for many football players who experience injuries as part of the game. The post WNBA Removes Marijuana From Banned Substances List And Sets Rules For Player Endorsements Of Hemp CBD Products appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A congressional committee is directing federal officials to continue requiring government employees and safety-sensitive workers such as truck drivers and airline pilots to be drug tested for marijuana, “regardless of any future changes to the legal status or scheduling.” The panel is separately urging agencies to focus on determining whether “commercially feasible technology” is available to help law enforcement detect cannabis-impaired driving, and is also supporting efforts to develop an “objective standard” to measure recent marijuana use. The House Appropriations Committee on Wednesday approved the Fiscal Year 2027 Transportation, Housing and Urban Development, and Related Agencies spending bill and an attached report that includes several cannabis-related provisions. One section, added during the markup via an amendment, notes that members are “aware of ongoing changes to Federal and State laws governing the legal status and scheduling of certain controlled substances” such as marijuana, and says that those reforms “should not be construed to alter existing Federal drug testing requirements applicable to Federal employees and individuals serving in safety-sensitive positions.” Workers in positions regulated by the Department of Transportation (DOT) should continue to be tested for cannabis and other drugs, “regardless of any future changes to the legal status or scheduling of such substances under Federal law,” it says. “Drug testing.—The Committee is aware of ongoing changes to Federal and State laws governing the legal status and scheduling of certain controlled substances. The Committee emphasizes that such changes should not be construed to alter existing Federal drug testing requirements applicable to Federal employees and individuals serving in safety-sensitive positions. The Committee directs DOT to continue requiring testing for marijuana, cocaine, opioids, amphetamines, phencyclidine (PCP), and any additional controlled substances included on the Federal drug testing panel for individuals occupying safety-sensitive positions regulated by the Federal Aviation Administration, Federal Motor Carrier Safety Administration, Federal Railroad Administration, Federal Transit Administration, and Pipeline and Hazardous Materials Safety Administration, regardless of any future changes to the legal status or scheduling of such substances under Federal law.” Last month, a pair of Republican lawmakers teamed up with anti-marijuana groups to push for a “carve-out” to ensure that safety-sensitive workers continue to be tested and punished for cannabis use. Days earlier, DOT had issued new guidance saying that truck drivers, airline pilots and other safety-sensitive workers still cannot use medical marijuana without punishment despite the Trump administration’s move to reschedule it. “Marijuana use is not compatible with safety-sensitive functions,” the agency said. Medical review officers (MROs) who receive drug test results indicating cannabis consumption cannot deem them to be negative for illegal substance use, even when an employee says it was the result of state-licensed medical marijuana, the department said. “Currently, there is no instance when the MRO could verify a laboratory-confirmed marijuana positive drug test result as ‘negative’ when an employee claims the positive was caused by a State licensed marijuana product,” DOT said, explaining that even after rescheduling, medical marijuana dispensed in accordance with state law “does not constitute” a drug that has been approved by the Food and Drug Administration (FDA). Adopted by voice vote. — House Appropriations Amendments (@AppropsAmendmts) June 4, 2026 While it is widely accepted that safety-sensitive transportation workers should not perform their jobs under the influence of marijuana or other substances, legalization supporters point out that cannabis metabolites can stay in a person’s system for weeks after use and still be detected on drug tests even when there is no impairment. The new report approved by the congressional committee also contains a passage saying that “as more jurisdictions legalize the use of recreational cannabis, law enforcement officers will need additional reliable tools to protect drivers and other road users.” It calls on the National Highway Traffic Safety Administration (NHTSA) to “assess currently available and potentially commercially feasible technology that could be used by highway enforcement authorities to assess cannabis presence.” “Cannabis-related impairment and technology.—The Committee recognizes that as more jurisdictions legalize the use of recreational cannabis, law enforcement officers will need additional reliable tools to protect drivers and other road users. The Committee directs NHTSA, in coordination with other relevant Federal agencies, to assess currently available and potentially commercially feasible technology that could be used by highway enforcement authorities to assess cannabis presence. The Committee directs NHTSA to provide a preliminary briefing on the plans for this assessment within 180 days of enactment of this Act. The Committee simultaneously supports the development of an objective standard to measure marijuana to identify recent cannabis use and/or a related field test to ensure highway safety.” Separately, the report addresses the issue of impaired driving more generally by urging NHTSA consider creating an interagency Impaired Driving Task Force and brief lawmakers on “any cross-agency initiatives to reduce the number of crashes and deaths associated with impaired driving.” “Interagency impaired-driving task force.—The Committee is concerned with the rising number of crashes associated with drivers operating their motor vehicles while impaired. The Committee notes the existence of the Federal Drug-Impaired Driving Working Group and urges NHTSA to consider the merits of creating an interagency Impaired Driving Task Force or other partnerships to increase cross-agency collaboration among Federal, State, and local levels to prevent and respond to impaired driving. The Committee directs NHTSA to brief the Committees on Appropriations regarding any cross-agency initiatives to reduce the number of crashes and deaths associated with impaired driving that are identified as a result of this collaboration.” Last month, a separate congressional committee approved transportation legislation containing provisions to require federal officials to study the issue of driving of driving under the influence of marijuana and other drugs and propose “evidence-based impairment standards.” The new funding bill itself that was approved by the Appropriations Committee in a 34-27 vote this week contains a provision blocking the NHTSA from using any of its appropriated monies to “encourage illegal drug or alcohol use” in its public service announcement advertising campaigns. “SEC. 141. None of the funds provided in this Act may be used to encourage illegal drug or alcohol use in the National Highway Traffic Safety Administration’s impaired driving advertising campaigns.” The rider is seemingly in response to previous marketing materials that leaned into cannabis culture to deter impaired driving. Marijuana legalization opponents cheered when a similar provision was approved last year. Federal officials launched a public service announcement effort to discourage impaired driving around the cannabis holiday 4/20 this year. NHTSA recently partnered with the Ad Council on a separate campaign to “challenge the dangerous belief that it’s safe to drive after consuming marijuana,” with a disturbing ad that they said depicts a real-life story of a child killed by a driver who was under the influence of cannabis. That campaign represented a departure from recent cannabis-related NHTSA ads, which have taken a less “Just Say No” approach to marijuana use risk messaging and, at times, leaned into to cannabis culture to promote education around the potential consequences of driving while high. What stood out about the messages and graphics was the lack of fear-mongering and negative depictions of cannabis consumers that’s long been a hallmark of federal marijuana PSAs, such as those funded by the White House Office of National Drug Control Policy (ONDCP) in the 1990s and 2000s that perpetuated stigmas about laziness or forgetfulness. Instead, NHTSA seemed to be leveraging cannabis culture, with warnings against impaired driving that are coupled with images meant to appeal to marijuana consumers. Last October, Transportation Secretary Sean Duffy suggested President Donald Trump was “getting pressure” to reschedule cannabis—arguing that marijuana is “really addictive” and saying that policy reform around the issue sends a “dangerous” message. “At a time when culture is pushing and celebrating the use of marijuana, we’re not talking about the risk,” Duffy said. NHTSA Administrator Jonathan Morrison said last year that he was prepared to “double down” on increasing awareness about the risk of marijuana-impaired driving in partnership with the White House. In 2021, meanwhile, NHTSA tried to get the word out about the dangers of impaired driving through an ad featuring a computer-generated cheetah smoking a joint and driving a convertible. Critics noted that the world’s fastest land animal hardly fits the stereotype of a cannabis consumer that the government has historically played into, while other commenters pointed out at the time that the ad made the cheetah look confusingly cool as he broke the law. The agency also played on horror-movie tropes in a 2020 ad featuring two men running for their lives from an axe murderer. The pair ultimately find a vehicle to escape the scene, but the driver pauses before he turns the key in the ignition. “Wait wait wait,” he says. “I can’t drive. I’m high.” While it’s widely understood that driving under the influence of cannabis can be dangerous, the relationship between consumption and impairment is a messy one. In 2024, for example, a scientific review of available evidence on the relationship between cannabis and driving found that most research “reported no significant linear correlations between blood THC and measures of driving,” although there was an observed relationship between levels of the cannabinoid and reduced performance in some more complex driving situations. “The consensus is that there is no linear relationship of blood THC to driving,” the paper concluded. “This is surprising given that blood THC is used to detect cannabis-impaired driving.” Meanwhile, the Department of Justice recently announced a new breakthrough in the development of a marijuana breathalyzer, with a study partly funded by the federal government showing a potential pathway for a “portable, low cost” device that looks like an inhaler for asthma, built with 3-D printed material that can detect delta-9 THC without secondary lab analysis. Federal agencies outside of DOJ have also recognized the need for the THC detection technology. For example, last year the National Institute of Standards and Technology (NIST) under the U.S. Department of Commerce planned a workshop aimed at facilitating “an open and candid discussion” about the development and implementation of device to test a person’s breath for marijuana impairment. In 2023, a federally funded report by researchers at NIST and the University of Colorado Boulder concluded that evidence does “not support the idea that detecting THC in breath as a single measurement could reliably indicate recent cannabis use.” A DOJ researcher in 2024, meanwhile, cast doubt on whether a person’s THC levels are even a reliable indicator of impairment, saying states may need to “get away from that idea.” That issue was also examined in a federally funded study in 2024 that identified two different methods of more accurately testing for recent THC use that accounts for the fact that metabolites of the cannabinoid can stay present in a person’s system for weeks or months after consumption. Also that year, researchers behind a federally funded study said they’d developed new procedures to enhance the selectivity of a popular forensic testing method, allowing better detection of delta-9 THC and its metabolites in blood. A study published in 2019 concluded that those who drive at the legal THC limit—which is typically between two to five nanograms of THC per milliliter of blood—were not statistically more likely to be involved in an accident compared to people who haven’t used marijuana. Separately, the Congressional Research Service (CRS) in 2019 determined that while “marijuana consumption can affect a person’s response times and motor performance … studies of the impact of marijuana consumption on a driver’s risk of being involved in a crash have produced conflicting results, with some studies finding little or no increased risk of a crash from marijuana usage.” In a report in 2024, NHTSA said there’s “relatively little research” backing the idea that THC concentration in the blood can be used to determine impairment, again calling into question laws in several states that set “per se” limits for cannabinoid metabolites. “Several states have determined legal per se definitions of cannabis impairment, but relatively little research supports their relationship to crash risk,” that report said. “Unlike the research consensus that establishes a clear correlation between [blood alcohol content] and crash risk, drug concentration in blood does not correlate to driving impairment.” The post Congressional Committee Directs Feds To Keep Testing Truck Drivers For Marijuana, Regardless Of Trump’s Rescheduling Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for a very interesting blog. What else may I get that kind of info written in such a perfect approach? I’ve a undertaking that I am simply now operating on, and I have been at the look out for such info. เว็บแทงบอล

I recently came across your blog and have been reading along. I thought I would leave my first comment. I don't know what to say except that I have enjoyed reading. Nice blog. I will keep visiting this blog very often. แทงบอลสเต็ป

A newly enacted Louisiana law will let patients with terminal and irreversible conditions use medical marijuana in hospitals. Gov. Jeff Landry (R) allowed the reform to be enacted without his signature on Monday, rather than signing or vetoing it. The House of Representatives had approved the legislation from Sen. Katrina Jackson-Andrews (D) in a 54-44 vote last month after it previously passed the Senate by a margin of 33-2 in April. Under the proposal, hospitals will have to create written guidelines allowing covered patients to consume medical cannabis on-site in forms other than smoking or vaping. Under an amendment adopted by a Senate committee last month, emergency or outpatient departments are exempted from the policy. The revised legislation also clarifies that patients and primary caregivers are responsible for acquiring and administering medical marijuana, which must be “stored securely at all times in a locked container provided by the patient.” Health care professionals and staff are prohibited from “administering, storing, retrieving, or assisting the patient with the medical marijuana,” the text says. The amendment, which the sponsor worked on with help from the Louisiana Hospital Association, also allows hospitals to opt out of the policy if federal officials take action against any healthcare facility in the state over medical cannabis use, rather than only allowing those that were specifically targeted to stop complying. “This bill was brought at the request of constituents who believe that therapeutic medical marijuana, which is already legal in this state, should be offered in hospitals when patients are terminally ill or otherwise in need the comfort of this medicine,” Jackson-Andrews told the Senate Health and Welfare Committee when the panel took up the legislation. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile in Louisiana, another piece of drug policy legislation that is before the governor for action would create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin, ibogaine and MDMA. At the same time, however, advocates are alarmed that Landry recently signed legislation that threatens to send people to jail for up to one year if they smoke marijuana within 2,000 feet of a school property—including a college campus. The governor said in a video posted to social media that he is “tired” of smelling cannabis at football games. Separately, a lawmaker recently filed a proposal that would create a new state task force to “study and develop findings and recommendations regarding the potential legalization of recreational marijuana”—though it did not advance. Another Louisiana legislator, meanwhile, recently introduced a bill to create an adult-use marijuana legalization pilot program in the state to determine whether the reform should eventually be expanded and permanently codified. Rep. Candace Newell (D)—who has long championed legislation to end cannabis criminalization and filed a similar legal marijuana pilot program measure last session—is sponsoring what’s titled the “Adult-Use Cannabis Pilot Program Regulation and Enforcement Act.” Newell’s earlier version of the pilot program legislation didn’t advance to enactment last year, and lawmakers that session also rejected other marijuana reform proposals such as one that would have established a tax system to prepare the eventual legalization of adult-use cannabis. Meanwhile in Louisiana, Attorney General Liz Murrill (R) recently joined and then days later withdrew from a lawsuit challenging the Trump administration’s federal marijuana rescheduling move. Photo courtesy of Brian Shamblen. The post Louisiana Will Let Terminally Ill Patients Use Medical Marijuana In Hospitals After Governor Allows Bill To Take Effect Without His Signature appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with extra information? It is extremely helpful for me. แทงบอลสเต็ป

I wanted to thank you for this excellent read!! I definitely loved every little bit of it. I have you bookmarked your site to check out the new stuff you post. เว็บแทงบอล

Thanks for the blog loaded with so many information. Stopping by your blog helped me to get what I was looking for. แทงบอล

“I will be able to remove some very dangerous pharmaceuticals, and I’ll be able to replace them with something that God put on this earth.” By Anna Barrett, Alabama Reflector Amanda Taylor, a patient advocate, bought the first medical cannabis product in Alabama Wednesday morning at Callie’s Apothecary in Montgomery. Taylor, who has multiple sclerosis, said she has advocated for the natural medicine in her home state for about 11 years. She moved to Arizona for access to medical cannabis and to work in the industry, but came home to be a “voice for the patients.” “I’ve always said it’s not all about me, it’s about the patients. If it was about me, I would have stayed in Arizona, but this is about a better quality of life, not getting high, but about a better quality of life,” she said. The Alabama medical cannabis law, enacted in 2021, allows registered physicians to recommend cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s Disease, PTSD, sickle-cell anemia, chronic pain and terminal diseases. The approved product forms are restricted to tablets, tinctures, patches, oils and gel cubes (only peach flavor), with raw plant material and smokable forms remaining prohibited. Taylor purchased a water-soluble tincture and peach-flavored gel cubes. She said she hopes the products will last her about a month and resolve her nausea, vomiting and tremor symptoms of multiple sclerosis. She has 45 legions on her brain and one on her spine. “I will be able to remove some very dangerous pharmaceuticals, and I’ll be able to replace them with something that God put on this earth for this specific reason,” she said. Taylor drove over two hours from Cullman, Alabama, to get to Callie’s Apothecary, the first medical cannabis dispensary to open in the state. When the program is fully up and running, there will be 12 dispensaries across the state between four companies. Three of the companies, CCS of Alabama, LLC, GP6 Wellness, LLC and RJK Holdings, LLC, have licenses and are expected to open their storefronts this summer, according to Alabama Medical Cannabis Commission (AMCC) Director John McMillan. A fourth license is pending litigation, but is likely to go to Yellowhammer Medical Dispensaries, LLC. People who suffer from the qualifying conditions must get approval from their physician and enter the patient registry in order to buy products at a dispensary. Litigation has also held up access to medical cannabis. Some firms sued the commission for not being awarded a license, citing a discriminatory process. Another case involved five parents that sued the commission over delays in access to cannabis, which was dismissed in August. McMillan said Wednesday there are over 300 patients on the registry. As of Wednesday, there are 52 physicians certified to recommend medical cannabis to patients in Alabama, according to the Alabama Board of Medical Examiners, but there will likely be more now that patients can get products. “It’s all about the patients, every step of the whole process, and so I think wisely they’ve sort of held off until they know that the patient can get a recommendation and then get a product,” McMillan said. Taylor said she hopes that the stigma around cannabis as medicine will go away as the industry changes in Alabama. “I see this growing exponentially, because once people see the results and see the difference that it makes, and that it’s not about getting high and how you can function and be a productive member of society,” she said. “There’s no shame in that. This is medicine.” This story was first published by Alabama Reflector. The post Alabama Medical Marijuana Sales Finally Launch, Years After Lawmakers Passed Legalization appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A pair of Republican lawmakers sent a letter to the Trump administration’s treasury secretary on Wednesday saying they are “concerned” and “troubled” that marijuana businesses will be eligible for tax relief now that cannabis is being partially rescheduled under federal law. Moving marijuana from Schedule I of the Controlled Substances Act (CSA) to Schedule III will have “significant implications for the federal tax treatment of marijuana businesses,” Sen. James Lankford (R-OK) and Rep. Jodey Arrington (R-TX), who chairs the House Budget Committee, wrote in a letter to Treasury Secretary Scott Bessent. That’s because an Internal Revenue Service code known as 280E, which has prevented them from taking ordinary tax deductions and credits that are available to most businesses, only applies to Schedule I and II substances. “We have long been concerned about the potential fiscal and societal consequences of rescheduling,” the GOP lawmakers said, citing legislation that previously introduced called the No Deductions for Marijuana Businesses Act that would continue to prevent the cannabis industry from escaping the 280E penalty even under rescheduling. Under an order issued by Acting Attorney General Todd Blanche last month, marijuana regulated by a state medical cannabis license immediately moved to Schedule III. Marijuana products such as those in state-legal recreational markets remain in Schedule I for now, however, subject to a hearing process set to begin next month to consider broader rescheduling of cannabis. Lankford and Arrington said in the letter to the treasury secretary that they are “particularly troubled” by the notion that marijuana businesses could be eligible for retroactive relief that stretches back into past tax years prior to rescheduling. “Many state-licensed marijuana operators participate in both medical and recreational markets, making it unclear how Treasury would distinguish business activities that qualify or do not qualify for federal tax treatment,” they said. “The shortcomings of relying on inconsistent state licensure are already evident. For example, having a state license to grow or sell marijuana in Oklahoma does not mean that the business acts lawfully. At the height of its medical marijuana program, Oklahoma had 9,178 licensed marijuana growing operations. While law enforcement has worked diligently to close down many of these operations that violated the law, they were all at one point state licensed marijuana businesses. There are documented instances where licensed operations funneled marijuana to the black market and engaged in other crimes, like money laundering and human trafficking. Many of these operations have also been owned and operated by Chinese nationals who have exploited state marijuana laws to commit crimes.” “Across the country, businesses follow a patchwork of laws to become a licensed marijuana business,” the lawmakers wrote in the new letter. Some may be more stringent than others, but it remains the case that state licensure alone does not guarantee legal compliance or justify eligibility for federal tax benefits.” Lankford and Arrington asking Bessent to answer a series of questions about the issue by June 29th: Can you further clarify the definition of “retrospective tax relief” in this context? How many prior tax years is the Treasury Department planning to consider for tax relief for marijuana businesses? How will the Treasury Department ensure that marijuana businesses that are potential candidates for tax relief have not violated any law, including the diversion of marijuana to the black market, human trafficking, and money laundering? What is the estimated reduction in federal revenue associated with providing marijuana businesses access to ordinary business deductions and credits? How would providing retrospective tax relief to marijuana businesses help American families? What would be the impact on annual federal deficits and the national debt to give certain marijuana business owners a newly created retroactive tax benefit? What statutory authority permits the federal government to give business owners who sold or manufactured a product against federal law a tax benefit? Separately on Wednesday, Lankford told Bessent at a Senate Finance Committee hearing that “in Oklahoma, we had a massive influx of Chinese illegal aliens that moved into our state and set up illegal grow operations for marijuana and started shipping it literally all over the country.” “It was a tragic thing to be able to watch what happened,” he said. In Oklahoma, we witnessed a massive influx of Chinese illegal aliens set up illegal marijuana grow operations and ship product all over the country. The human trafficking, labor trafficking, and sex trafficking that came with it was a tragedy. I look forward to working with… pic.twitter.com/8Z4eCM7SVr — Sen. James Lankford (@SenatorLankford) June 3, 2026 Last week, a group of congressional Democrats sent a latter asking Bessent and Internal Revenue Service (IRS) Chief Executive Officer Frank Bisignano to issue “prompt guidance” on tax issues for marijuana businesses in light of the Trump administration’s move to federally reschedule cannabis. “The absence of clear and timely guidance for the cannabis industry will leave taxpayers uncertain as to how they can benefit from the tax code—whether it is the treatment of ordinary and necessary business deductions or accessing of tax credits,” the lawmakers wrote. The U.S. Department of the Treasury and IRS said in April that they plan to soon issue guidance on tax issues for marijuana businesses stemming from rescheduling, but that hasn’t yet happened. In their announcement about forthcoming guidance, IRS and Treasury said they “expect DOJ’s action to have significant positive tax consequences for businesses in the medical marijuana industry.” “Accordingly, rescheduling generally removes section 280E as a bar to claiming deductions and credits for businesses that as a result of the Final Order no longer traffic in Schedule I or II controlled substances under the CSA,” they said. Because of the way the rescheduling action is being rolled out in phases, state-licensed marijuana companies that serve both the medical and recreational markets may only be able to immediately obtain tax relief for parts of their businesses. “Guidance is expected to clarify the ways in which, for businesses with multiple activities, section 280E applies only to those activities related to trafficking in Schedule I or II controlled substances (e.g., by apportioning expenses),” the tax agency and Treasury Department said. Blanche’s rescheduling order for DOJ said he “encourages” the treasury secretary “to consider providing retrospective relief from Section 280E liability for taxable years in which a state licensee operated under a state medical marijuana license.” But the Treasury and IRS announcement said that, at least for an initial transition rule, “rescheduling generally will be considered to first apply for a business’s full taxable year that includes the effective date of the Final Order, for the business’s activities that do not involve Schedule I or II controlled substances as a result of the Final Order.” The agencies did not specify when they expect to issue the forthcoming guidance. The post GOP Lawmakers Are ‘Troubled’ About Marijuana Businesses Getting Tax Relief Under Trump’s Rescheduling Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I like your post. It is good to see you verbalize from the heart and clarity on this important subject can be easily observed... สมัครแทงบอล

VA marijuana push heats up; IA gov signs medical cannabis expansion; WY AG objects to rescheduling; PA medical cannabis in hospitals bill passes Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Six Wisconsin Democratic gubernatorial candidates spoke at a forum hosted by a cannabis group—making pledges to advance marijuana legalization, protect hemp businesses and use their pardon powers if elected. The Virginia legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market held its first meeting since Gov. Abigail Spanberger (D) vetoed bills to legalize recreational marijuana sales—with lawmakers discussing the possibility of putting the reform in budget legislation that’s due this month. Iowa Gov. Kim Reynolds (R) signed a bill to double the number of medical cannabis dispensaries that can be licensed, while also letting out-of-state residents register in the program if they have a certification from an Iowa healthcare provider. Wyoming Attorney General Keith Kautz (R) issued a formal “objection” to rescheduling marijuana under state law via a policy that would otherwise be automatically triggered by the Trump administration’s reclassification of cannabis at the federal level. The Pennsylvania House of Representatives passed a bill to allow terminally ill patients to use medical cannabis in hospitals, long-term care nursing facilities, assisted living residences and other healthcare centers. / FEDERAL The House bill to federally legalize marijuana got one new cosponsor for a total of 72. The House bill to allow marijuana businesses to list on stock exchanges got one new cosponsor for a total of four. The House bill to regulate hemp products got one new cosponsor for a total of seven. The House bill to delay the federal recriminalization of hemp THC products got two new cosponsors for a total of 36. / STATES Kentucky Gov. Andy Beshear (D) tweeted, “Medical cannabis has been found to decrease dependency on dangerous opioids and help people suffering reclaim their lives. We kept our promise to Kentuckians, and now every step of the medical cannabis process is complete as we deliver a safe alternative for pain relief.” Oklahoma Republican gubernatorial candidate Chip Keating said lawmakers have “grotesquely failed” to address illegal marijuana cultivation operations. New York lawmakers sent Gov. Kathy Hochul (D) legislation to address inversion of cannabis products from outside the state. South Carolina’s Senate majority leader said he doesn’t think the votes are there in his chamber to support a ban on hemp THC drinks. Alabama’s first medical cannabis dispensary is expected to open on Thursday. Washington, D.C. regulators cleared a business to get a medical cannabis dispensary license in the face of challenges concerning nearby daycare centers. Minnesota regulators extended the deadline to apply for a grants program supporting farmers, organizations and technical assistance providers entering the cannabis industry. California regulators sent updates on various cannabis issues. / LOCAL Los Angeles, California voters approved a ballot measure to impose taxes on unlicensed cannabis businesses. / INTERNATIONAL U.S. officials are investigating two more Mexican state governors over potential ties to drug cartels. / SCIENCE & HEALTH A study found that “THC usage among pediatric patients with positive [urine drug screens] did not increase with state legalization, nor did co-ingestion rates.” A study of mice found that “cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology.” / ADVOCACY, OPINION & ANALYSIS Disabled American Veterans published a post on military veterans’ therapeutic use of ibogaine. / BUSINESS Curaleaf Holdings, Inc. announced that its 1-for-3 reverse stock split will become effective on Friday. / CULTURE MMA fighter Daniel Rodriguez spoke to Joe Rogan about spending eight months in prison in Mexico over marijuana. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Wisconsin governor candidates pledge cannabis action if elected (Newsletter: June 4, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Ragdoll Hit is a game where you win battles and collect coins. With those coins, you can unlock new characters with better armour and weapons, which will help you survive longer in the matches. Get enough coins to equip one of these weapons: bat, staff, kanabo, nunchaku, butterfly, katana, sword, holy blade, etc.

Stylish evenings become much more dynamic with premium Dwarka Escorts Service providing attractive companions who create classy vibes and create unforgettable luxury experiences.

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with extra information? It is extremely helpful for me. แทงบอลสด

Every time you fall in Wacky Steps, the game does not punish you with a harsh game over screen, it rewards you with a hilarious animation of your character tripping, spinning, and collapsing in the most ridiculous way possible.

A top Wyoming state official has filed a formal objection to rescheduling marijuana under state law, a reform that would otherwise be automatically triggered by the Trump administration’s move to reclassify cannabis on the federal level. “The Wyoming Legislature has not legalized medical marijuana, has not approved a state licensed medical marijuana regulatory scheme, or approved of recognizing any other state’s medical marijuana issued licenses,” Attorney General Keith Kautz (R) said. “Therefore, placing marijuana subject to a state medical marijuana license in Schedule III of the Wyoming Controlled Substances Act is inconsistent with the police powers exercised to date by the Wyoming Legislature.” “The question of whether to remove any type of marijuana from Schedule I of the Wyoming Controlled Substances Act is for the Wyoming Legislature and should not be done through the administrative rule making process,” he said. The legislature, however, previously enacted a law that says “if any substance is designated, rescheduled, or deleted as a controlled substance under federal law,” the commissioner of drugs and substances control “shall control the substance under this act in the same manner as federal law” within 30 days. Under state law, the attorney general serves as the commissioner of drugs and substances control and can formally object to the automatic state rescheduling to prevent it from taking place, subject to a public hearing allowing “all interested parties an opportunity to be heard.” The hearing on cannabis that is being triggered by the attorney general’s objection will be held on June 18 at the Wyoming State Capitol. “All marijuana products currently approved by the United States Food and Drug Administration are already scheduled consistent with the federal Controlled Substances Act,” Kautz said in his announcement, which was published on May 27. “Dronabinol, which contains synthetic delta-9-tetrahydrocannabinol, is listed in Schedule III of the Wyoming Controlled Substances Act; Cesamet, which contains a synthetic compound chemically similar to tetrahydrocannabinol, is listed in Schedule II of the Wyoming Controlled Substances Act; and Epidiolex, which contains pure cannabidiol, was removed from control in 2020.” Under an order issued by U.S. Acting Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). An administrative hearing scheduled for this month will consider broader cannabis rescheduling, including for recreational products. In Wyoming, activists have sough unsuccessfully to put initiatives to legalize medical cannabis and decriminalize marijuana possession on the ballot. State lawmakers have also considered legislation on the issue, but Wyoming remains one of only a handful of states without any legal medical marijuana access. In 2022 the Wyoming House speaker filed a bipartisan decriminalization bill to remove criminal penalties for possessing small amounts of cannabis and replace the state’s current misdemeanor charge with a $100 fine. But that legislation did not receive a vote despite support from top GOP lawmakers. A bill to legalize and regulate cannabis for adult use in Wyoming advanced out of a House committee in 2021, but it did not move further by the end of that session. A poll released in 2020 found that 54 percent of Wyoming residents supported allowing adults in the state “to legally possess marijuana for personal use.” Meanwhile, other states that also don’t have comprehensive medical cannabis programs are also grappling with changes to state marijuana laws that could be trigged by the federal rescheduling action. A GOP senator in South Carolina, for example, said that “medical marijuana is now legal” in the state under a trigger law. Last month, the governing body of the Alabama Department of Public Health voted to object to federal rescheduling of marijuana after health officials said they need more time to determine how to implement a change on the state level. Tennessee Gov. Bill Lee (R), meanwhile, signed legislation this session to block an automatic review that could have potentially legalized medical marijuana under state law following the federal rescheduling of the drug. The post Wyoming Official Issues ‘Objection’ To Rescheduling Marijuana Under State Law Following Trump’s Federal Move appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Iowa’s governor has signed a bill that will double the number of medical cannabis dispensaries that are allowed to operate in the state. Under prior law, Iowa’s limited medical marijuana program allowed only five dispensaries. That will double to 10 under HF 990, which Gov. Kim Reynolds (R) approved on Tuesday. The measure was passed by the House of Representatives in an 88-5 vote in April and previously cleared the Senate in a tally of 42-5. Bridget Spiddle, public policy and communications coordinator for the Marijuana Policy Project (MPP), wrote in an action alert to supporters last month that the reform will be “a vital step in expanding medical cannabis access for one of the most restrictive medical cannabis programs in the country.” “No other medication gets treated like cannabis does. Pharmacies are widely accessible throughout Iowa, while dispensaries are capped at five locations for thousands of patients,” she said. “Rural Iowans have to expend enormous amounts of time and resources on costly travel to receive their medicine.” In addition to doubling the dispensary allowance, the new law the governor signed will also allow out-of-state residents to register in the medical cannabis program if they have a certification from an Iowa healthcare provider. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The Iowa Medical Cannabidiol Board, which oversees the state’s medical marijuana program, recommended in a 2023 report that the state allow more licenses “in an effort to provide Iowans with greater geographical access to medical cannabis products.” Under the program, patients with certain conditions can obtain cannabis products containing no more than at 4.5 grams of THC every 90 days. Flower and smoking are not allowed. Healthcare practitioners can allow greater amounts of THC for patients who are terminally ill or who have experience with the program and for whom the provider believes 4.5 grams is not enough. Separately this session, Iowa lawmakers considered a bill to create a state-regulated therapeutic psilocybin program for patients with post-traumatic stress disorder (PTSD). Last year, the governor vetoed earlier legislation that would have allowed doctors in the state to immediately prescribe a synthetic form of psilocybin in the event of federal approval of the psychedelic substance by the U.S. Food and Drug Administration (FDA), arguing that it “surrenders state authority to make an informed determination about classification to federal officials.” The post Iowa Governor Signs Bill Doubling The Number Of Medical Marijuana Dispensaries That Can Operate appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Pennsylvania lawmakers have approved a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities. The House of Representatives passed the bill from Rep. Dan Frankel (D) in a 174-27 vote on Monday. It now heads to the Senate for consideration. If enacted into law, HB 2254 would require hospitals, long-term care nursing facilities, assisted living residences and personal care homes to allow terminally ill patients to use medical cannabis on the premises, provided that doing so does not interfere with their broader treatment plan and that marijuana isn’t vaporized in a way that “could impact care to other patients.” Smoking cannabis is not allowed under Pennsylvania’s broader medical marijuana law. Within 180 days of the bill being enacted, covered healthcare facilities would have to “develop and disseminate written guidelines for the use or administration of medical marijuana.” That would need to include requirements that cannabis be stored in locked containers, safety measures to protect other patients and staff, specificity on the forms of marijuana that are allowed and procedures for documenting use. “Today we have the opportunity to come together to ease the suffering of patients at the end of their lives,” Frankel said on the House floor ahead of the vote. “In a few moments we will cast our votes to ensure that patients nearing the end of their lives are not denied access to medical cannabis simply because they receive care in a hospital—but what House Bill 2254 really does is give some very sick people the chance to spend their final days conscious, comfortable and connected to the people they love.” “Many of us in this chamber have sat beside the bed of a loved one in their final hours,” he said. “We know the value of one more conversation, one more squeeze of the hand, one more chance to say, ‘I love you.’ Today, with this vote, we can help give that gift to Pennsylvania families.” The legislation says that facilities are not required to administer medical cannabis to patients to to allow its use in emergency departments, but it also says that those that facilities violate the broader policy on allowing use can be assessed a civil penalty of up to $500 for each violation for each day a violation continues. The measure also provides that if the Department of Justice, Centers for Medicare and Medicaid Services or another federal agency takes action against a healthcare facility over the use of medical cannabis, facilities should suspend compliance with the law. Finally, the bill would require the state Department of Human Services to prepare a sample medical marijuana plan for healthcare facilities and to host at least five educational sessions about the issue. “The needs of terminally ill patients were a key consideration when Pennsylvania enacted the Medical Marijuana Act. The law includes provisions allowing patients in care facilities to access medical marijuana by designating a caregiver to administer and even permits facility staff to serve in that role,” Frankel wrote in a cosponsorship memo for the legislation prior to formally introducing it this session. “While some facilities in Pennsylvania have chosen to permit the use of medical marijuana, adoption remains inconsistent across the state. As a result, many terminally ill patients continue to face barriers to accessing medical cannabis during inpatient or end-of-life care.” “This measure will ensure patients have access to effective symptom relief while maintaining safety and compliance within care settings,” he said. The medical cannabis bill’s advancement comes as lawmakers in Pennsylvania continue to consider broader recreational marijuana legalization—a reform that a state senator recently said will be easier to achieve now that the Trump administration has rescheduled cannabis at the federal level. Gov. Josh Shapiro (D) has repeatedly called on lawmakers to send him a marijuana legalization bill and for the last several years has included the reform in his budget requests to the legislature. The Democratic-controlled House of Representatives passed a bill last year to end prohibition, but the Republican-controlled Senate has not followed suit. Republican gubernatorial nominee Stacy Garrity, who is running against Shapiro, recently pledged to veto a marijuana legalization bill if lawmakers ever sent one to her desk—though she added that she doesn’t think the reform stands a chance of making it that far in the state. “I don’t support legalizing recreational marijuana,” she said. “Recreational marijuana will not end up in the budget. They’re never going to pass it…not as long as Senate Republicans are in control of the Senate.” Her running mate for lieutenant governor, Jason Richey, claimed that legalizing marijuana would be “catastrophic” for the state, arguing it would increase the size of the illegal market, undermine job creation and harm public health. A spokesperson in the governor’s office said the Trump administration’s federal marijuana rescheduling move is an “important step” that “adds support” to his push to legalize cannabis in the state. The governor also used this year’s unofficial cannabis holiday 4/20 as an opportunity to press lawmakers once again to send him a bill to legalize marijuana. “Pennsylvanians who want to buy recreational marijuana are already driving across the border to one of our neighboring states who’ve legalized it,” Shapiro said in a social media post that day. “That’s hundreds of millions in revenue going out of state instead of being spent here in Pennsylvania.” In April, the Pennsylvania House of Representatives passed budget legislation proposed by Shapiro that relies on revenue that would be generated from recreational marijuana sales, which has yet to be legalized in the state. The governor earlier this year, as he has in past years, included cannabis legalization and the resulting expected revenue in his budget request. The $53.2 billion budget legislation, which doesn’t itself include provisions to actually legalize marijuana even as it contemplates allocating money that would result from it, now heads to the Senate for consideration. The House of Representatives last year passed a bill to legalize marijuana and put sales in state-owned dispensaries, but the Republican Senate majority has criticized that plan while also not advancing a cannabis legalization model of its own. Separately this session, lawmakers have advanced a bill to allow terminally ill patients to use medical cannabis in hospitals and other healthcare facilities The legislative developments come as a recent poll shows that seven out of ten Pennsylvania likely voters support legalizing adult-use marijuana—including majority backing for the reform across party lines. When asked whether they “support or oppose the regulation and taxation of legal cannabis for use by adults 21 and older in Pennsylvania,” 69 percent of respondents said yes. Support was strongest from Democrats, at 72 percent, but also includes 67 percent of Republicans and 64 percent of independents. Meanwhile, Shapiro is continuing to pressure on lawmakers to send him a bill to legalize marijuana in the state, saying that doing so would generate new revenue that could be invested in key programs. “While some in Harrisburg claim we can’t afford to make bigger investments in our kids, public safety, and our economy, know this: If we legalized and regulated adult-use cannabis, we’d bring in $1.3 BILLION in revenue for our Commonwealth over the first five years,” the governor said in another recent social media post. “Those are dollars that can be invested back into our people and our communities,” he said. “Stop with the excuses. Let’s get this done.” The state’s Independent Fiscal Office (IFO) reported in February that legalizing cannabis in Pennsylvania would generate nearly half a billion dollars in annual revenue by 2028, an estimate that is a significantly larger cash windfall compared to projections from Shapiro’s own office. With a proposed 20 percent wholesale cannabis excise tax, 6 percent state sales tax for retail and licensing fees, IFO said the governor’s legalization plan would generate $140 million in tax revenue in the first year of implementation from 2027-2028 and increase to $432 million by 2030-2031. That’s a much higher revenue estimate than what the governor’s office put forward in the latest executive budget. According to his office’s analysis, legalization would generate about $36.9 million in tax dollars in its first year from a 20 percent wholesale tax on marijuana—rising gradually to $223.8 million by 2030-2031. In February, a coalition of drug policy and civil liberties organizations urged Shapiro to play a leadership role in convening legislative leaders to get the job done on cannabis legalization this session. The Senate Law and Justice Committee last month amended and approved a bill to create a Cannabis Control Board (CCB) to oversee the state’s medical marijuana program and intoxicating hemp products and that could eventually regulate adult-use cannabis if it is legalized in the state. The post Pennsylvania Lawmakers Pass Bill Allowing Medical Marijuana Use In Hospitals By Terminally Ill Patients appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thank you very much for this useful article. I like it. เว็บแทงบอลออนไลน์

Most of the contenders for Wisconsin’s Democratic gubernatorial nomination appeared at a forum hosted by a cannabis reform group on Tuesday, making pledges to advance the cause of legalization if elected even in the face of potential opposition from Republican legislative leaders. The event, hosted by the Wisconsin Coalition for Cannabis Reform (WCCR), featured six candidates who spent roughly 80 minutes discussing their plans for both protecting the state’s legal hemp market amid looming federal changes as well as the push for broader marijuana legalization. Among other issues, the participants fielded a question submitted by Marijuana Moment about how they would plan to fight for cannabis reform if GOP Senate and Assembly leaders continue to oppose it as they have in recent sessions—including if they would pledge to take any unilateral executive actions on the issue to get around legislative roadblocks. Lt. Gov. Sara Rodriguez said “it’s a good question,” pledging to both put public pressure on lawmakers to advance legislation but also use her own powers as governor to grant relief to people with cannabis convictions and to direct state agencies to immediately begin building a regulatory framework for marijuana sales “so it’s ready to go when the bill passes, not a couple years for implementation.” “Here’s where I would start, which is the people of Wisconsin,” she said. “Their votes were already on the record when they’ve been asked directly” through nonbinding advisory ballot questions during past elections. “The first thing is to take those numbers into those purple districts, and I will stand in the backyard of every swing seat Republican blocking this, and remind their own voters that they’re being ignored,” she said. “That’s the bully pulpit. That’s what the governor’s office is for, and I will not be shy about using it.” The lieutenant governor also said that, like incumbent Gov. Tony Evers (D), she would put cannabis reform into her budget proposals to force lawmakers to at least perfunctorily consider the issue and would also call the legislature into special session to consider the issue. “Yeah, they can gavel in and gavel out like they’ve been doing, but then they’ve refused on the record in public in an election year that they don’t want to do this,” she said. “Explain that to the farmers and small business owners back in their own district.” Rodriguez noted that some Republican lawmakers are starting to come around at least on incremental medical cannabis legalization legislation, with a bill on that reform advancing through committee this session. “We can get them there when there’s movement, and then you build from that,” she said. State Sen. Kelda Roys similarly cited strong public support for cannabis reform, saying “there is the opportunity to build a broad coalition of stakeholders.” She noted that recent redistricting in the state could allow Democrats to capture at least one chamber of the legislature in the upcoming elections. “If we have a split legislature, we may have to bifurcate the issues to immediately help provide relief to cannabis businesses and our hemp producers, and then tackle the question of how do we go to full adult legalization in the coming months,” she said. “Of course, you can use the bully pulpit, but at the end of the day, it is about building relationships.” Roys noted the “real angst” being experienced by hemp industry operators who are “facing the death of their business this coming November” if a scheduled federal recriminalization of hemp THC products takes effect. “I will use my pardon powers and my clemency powers, not just to push for justice for those that have been convicted of cannabis-related crimes,” she said, “but to make sure that anybody who is continuing to try to operate their business can do so in that few-month period when they may be out of compliance with state law.” “Now, I can’t do anything related to federal law,” Roys said. “But I can give you some certainty that under state law we’re going to make sure that you are not faced with any kind of penalty or criminal, and I will do everything in my power to make sure that you can continue your business and continue making Wisconsin a place where every single person has the opportunity to thrive.” Mandela Barnes, who previously served as lieutenant governor alongside Evers, noted that there will be a change in legislative leadership regardless of which party has a majority, due to the fact that Assembly Speaker Robin Vos (R), who has consistently opposed comprehensive medical cannabis reform, is retiring after this year. “This offers new negotiating opportunities and potential. We know full well that the current speaker was one of the biggest roadblocks” to marijuana reform. “Now we have a chance to change that.” Barnes said he would use the issue of marijuana reform as a “bargaining chip.” “If I am elected governor, we will use every single tool at our disposal to do so,” he said. “There are Republican legislative districts that have…been plagued with lack of resources, with stagnant funding, with deferred maintenance, be it the roads, with funding constraints. When it comes to education, we see school districts going insolvent.” “This is the way for us to do it, and I am happy to use this issue as a bargaining chip to ensure that all of our schools get the funding that they deserve when competing against backwards legislators, regressive legislators who don’t want to see this come to fruition. When it comes to fixing these roads, when their constituents are calling them, wondering when things are going to change, we have an easy answer. We have an easy fix, and it is irresponsible for them to continue to say no. It is a drain of resources on law enforcement and our court system, in addition to not being able to generate the revenue that we deserve.” “So I’m ready to go to the mat on this, along with several other issues that are high importance in the upcoming legislative session,” he said. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — State Rep. Francesca Hong said reform can advance under “leadership that understands how to build power, how to be a community organizer, and ensure that our relationship building is front and center.” She said the state needs “executive leadership that is willing to wield the full power of the executive office to make sure that we are protecting people from the decisions from the Trump regime and make sure that for generations, our future generations here in Wisconsin, that we are creating a framework where the industry not only can continue to grow, but we are able to be a leader in this industry for other states as well.” Milwaukee County Executive David Crowley said reform supporters “cannot wait until after the governors election” to push the issue, arguing that they need to “organize in making this one of the top priorities in this upcoming election.” “If you can’t change minds, you have to change faces,” he said. “I want you all to know that we’re going to work directly with you and make sure that you have a seat at the table, because if you don’t have a seat at the table, that means you’re on it.” Joel Brennan, who previously served as secretary of the state Department of Administration, noted the possibility of changing the composition of the legislature in the November election. “We have an environment where we have opportunities to make things happen, but we’re going to have the thinnest of majorities, no matter what,” he said. “And I think what that requires are muscles that nobody in the legislature over the last 15 or 20 years have exercised, which is—how do you find allies that might be different on this issue versus that issue?” “If we have a trifecta, that makes things much easier. But even with that, it may be a one or two seat majority, and if the majority is in the on the other side, it will require relationships… I also think it’s going to require the governor to have the kind of relationships, and to be the kind of person who is going to be able to take some of those people in the legislature, some of them Democrats, some of them moderate Republicans, and bring them over the finish line. That’s the part of the job that I actually look forward to.” Jason Handal, a WCCR board member and vice president of the group, told Marijuana Moment after the event that the candidates’ comments—and that they appeared at the cannabis-focused group’s event—were significant. “I appreciate that we heard commitments to prioritize reform in multiple ways: directing agency action, establishing a transition team to ensure cross-agency coordination, building a single coalition across party lines, and otherwise using the full weight and authority of the governor’s office to ensure the right reforms are enacted,” Handal, who is also CEO of Kind Oasis, said. Democratic lawmakers filed legislation in the 2026 session to broadly legalize and regulate marijuana, and bipartisan legislation to simply decriminalize cannabis possession was also filed—but neither proposal advanced. A poll released last June by Marquette Law School found that two in three Wisconsin voters support legalizing marijuana. Evers, the incumbent governor, said last year that if his party can take control of the legislature, the state can “finally” legalize marijuana so that residents don’t have to go to neighboring Illinois to visit its adult-use market. A legislative analysis requested by lawmakers estimated that Wisconsin residents spent more than $121 million on cannabis in Illinois alone in 2022, contributing $36 million in tax revenue to the neighboring state. Meanwhile, the state Department of Revenue released a fiscal estimate of the economic impact of a legalization bill from then-Sen. Melissa Agard (D) in 2023, projecting that the reform would generate nearly $170 million annually in tax revenue. The post Wisconsin Democratic Governor Candidates Promise To Advance Marijuana Legalization And Protect Hemp In 2027 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I think this is an informative post and it is very useful and knowledgeable. therefore, I would like to thank you for the efforts you have made in writing this article. togel 4d Super-Duper site! I am Loving it!! Will come back again, Im taking your feed also, Thanks. ราคาบอลวันนี้ Fabulous post, you have denoted out some fantastic points, I likewise think this s a very wonderful website. I will visit again for more quality contents and also, recommend this site to all. Thanks. wop slot Wow! Such an amazing and helpful post this is. I really really love it. It's so good and so awesome. I am just amazed. I hope that you continue to do your work like this in the future also เว็บแทงบอลออนไลน์

I wanted to thank you for this excellent read!! I definitely loved every little bit of it. I have you bookmarked your site to check out the new stuff you post. แทงบอลออนไลน์

This is my first visit to your web journal! We are a group of volunteers and new activities in the same specialty. Website gave us helpful data to work. เว็บแทงบอลออนไลน์

I am impressed. I don't think Ive met anyone who knows as much about this subject as you do. You are truly well informed and very intelligent. You wrote something that people could understand and made the subject intriguing for everyone. Really, great blog you have got here. สมัครแทงบอล